"Gadolinium DTPA" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A complex of gadolinium with a chelating agent, diethylenetriamine penta-acetic acid (DTPA see PENTETIC ACID), that is given to enhance the image in cranial and spinal MRIs. (From Martindale, The Extra Pharmacopoeia, 30th ed, p706)
| Descriptor ID |
D019786
|
| MeSH Number(s) |
D02.092.782.590.401 D02.241.081.018.639.400 D02.691.400
|
| Concept/Terms |
Gadolinium DTPA- Gadolinium DTPA
- DTPA, Gadolinium
- Gadolinium Diethylenetriaminepenta-acetic Acid
- Diethylenetriaminepenta-acetic Acid, Gadolinium
- Gadolinium Diethylenetriaminepenta acetic Acid
- Gadopentetic Acid
- Gd-DTPA
- Gd DTPA
Gadopentetate Dimeglumine- Gadopentetate Dimeglumine
- Dimeglumine, Gadopentetate
- Gadolinium DTPA Dimeglumine Salt
- Gadolinium DTPA Dimeglumine
- Dimeglumine, Gadolinium DTPA
|
Below are MeSH descriptors whose meaning is more general than "Gadolinium DTPA".
Below are MeSH descriptors whose meaning is more specific than "Gadolinium DTPA".
This graph shows the total number of publications written about "Gadolinium DTPA" by people in this website by year, and whether "Gadolinium DTPA" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 0 | 2 | 2 |
| 1995 | 0 | 3 | 3 |
| 1996 | 0 | 2 | 2 |
| 1997 | 1 | 4 | 5 |
| 1998 | 0 | 4 | 4 |
| 1999 | 0 | 4 | 4 |
| 2000 | 0 | 3 | 3 |
| 2001 | 0 | 2 | 2 |
| 2002 | 2 | 2 | 4 |
| 2003 | 1 | 5 | 6 |
| 2005 | 2 | 3 | 5 |
| 2006 | 3 | 2 | 5 |
| 2007 | 2 | 5 | 7 |
| 2008 | 5 | 3 | 8 |
| 2009 | 2 | 2 | 4 |
| 2010 | 1 | 5 | 6 |
| 2011 | 3 | 4 | 7 |
| 2012 | 3 | 5 | 8 |
| 2013 | 1 | 2 | 3 |
| 2014 | 2 | 3 | 5 |
| 2015 | 0 | 3 | 3 |
| 2016 | 3 | 1 | 4 |
| 2017 | 1 | 0 | 1 |
| 2018 | 1 | 3 | 4 |
| 2019 | 1 | 3 | 4 |
| 2020 | 1 | 0 | 1 |
| 2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Gadolinium DTPA" by people in Profiles.
-
Multicenter Validation of Abbreviated MRI for Detecting Early-Stage Hepatocellular Carcinoma. Radiology. 2023 04; 307(2):e220917.
-
Prediction of HCC microvascular invasion with gadobenate-enhanced MRI: correlation with pathology. Eur Radiol. 2020 Oct; 30(10):5327-5336.
-
Comparison of ferumoxytol- and gadolinium chelate-enhanced MRI for assessment of sarcomas in children and adolescents. Eur Radiol. 2020 Mar; 30(3):1790-1803.
-
Myocardial Extracellular Volume Fraction Adds Prognostic Information Beyond Myocardial Replacement Fibrosis. Circ Cardiovasc Imaging. 2019 12; 12(12):e009535.
-
Tumor Contrast Enhancement and Whole-Body Elimination of the Manganese-Based Magnetic Resonance Imaging Contrast Agent Mn-PyC3A. Invest Radiol. 2019 11; 54(11):697-703.
-
Genetic variants of HIF1a are associated with right ventricular fibrotic load in repaired tetralogy of Fallot patients: a cardiovascular magnetic resonance study. J Cardiovasc Magn Reson. 2019 08 19; 21(1):51.
-
Pitfalls in liver MRI: Technical approach to avoiding misdiagnosis and improving image quality. J Magn Reson Imaging. 2019 01; 49(1):41-58.
-
Evaluation of Gadolinium Deposition in the Brain After MR Arthrography. AJR Am J Roentgenol. 2018 11; 211(5):1063-1067.
-
Can MRI help assess aggressiveness of endometrial cancer? Clin Radiol. 2018 09; 73(9):833.e11-833.e18.
-
Comparing the Performances of Magnetic Resonance Imaging Size vs Pharmacokinetic Parameters to Predict Response to Neoadjuvant Chemotherapy and Survival in Patients With Breast Cancer. Curr Probl Diagn Radiol. 2019 May - Jun; 48(3):235-240.